Streetbeat News

Stock Prices

EXTR

Extreme Networks has provided its Q1 guidance, projecting adjusted EPS between $0.10 and $0.14, compared to the estimated $0.12. The company also expects total net revenue to be in the range of $255 million to $265 million, against the estimated $259.6 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:08 am

VERX

Vertex reported its Q2 2024 results, with an adjusted EPS of $0.15, beating the estimate of $0.13. Sales also surpassed expectations, coming in at $161.104 million compared to the $160.664 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:07 am

SHOP

Shopify projects its Q3 2024 revenue to grow at a low-to-mid-twenties percentage on a YoY basis. The company expects a higher gross margin by 50 basis points compared to Q2 2024, GAAP operating expenses to be 41%-42% of revenue, and stock-based compensation to be $120 million. Free cash flow margin is expected to remain similar to Q2 2024, with a double-digit free cash flow margin for the rest of the year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:07 am

MDGL

Madrigal Pharmaceuticals reported its Q2 2024 financial results, with a GAAP EPS of $(7.10), beating the estimate of $(7.58). The company also reported sales of $14.638 million, significantly surpassing the estimate of $3.903 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:07 am

RDCM

RADCOM has raised its FY24 revenue guidance, revising the range from $57M-$60M to $58M-$61M, with an estimated $58.34M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:07 am

CVS

CVS Health shares are trading lower after the company reported worse-than-expected Q2 sales results and cut its FY24 adjusted EPS guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:07 am

SONY

Sony Group shares are trading higher after the company reported better-than-expected Q1 financial results and raised FY24 guidance.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:06 am

EXTR

Extreme Networks reported Q4 2024 adjusted EPS of $(0.08), missing the $0.13 estimate, but sales of $256.7M beat the $253.211M estimate.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:06 am

EDIT

Editas Medicine has announced that its cash balance of $318.3 million is expected to provide a cash runway into 2026.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 11:06 am

INTC

MSFT

Reuters reported that Intel passed on a $1 billion investment in OpenAI in 2018, which could have given it a stake of up to 30%, according to sources.

Portfolio Pulse from charles@benzinga.com

August 07, 2024 | 11:06 am